Clinical Trials Directory

Trials / Unknown

UnknownNCT05836662

Comparing Concussion Education Types

Comparison of Concussion Education Types

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Piya Sorcar · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if there are differences in knowledge, self-efficacy, and empathy surrounding concussions, as well as intent to report a concussion, after viewing concussion education (CrashCourse and Brain Fly-Through) in 2D versus in 3D. In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D).

Detailed description

In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D). During their in person study visit, participants will complete a brief ( \~5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants will then be asked to complete a brief ( \~2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions. Two months later, participants will receive a brief ( \~5 minute) follow-up survey via email, assessing the same constructs.

Conditions

Interventions

TypeNameDescription
OTHERCrashCourse Concussion Education in Virtual RealityThe TeachAids concussion education, including CrashCourse and Brain Fly-Through, will be shown in 3D (via a Virtual Reality headset). These educations are the exact same content as the 2D versions viewed on a laptop, but the modality (via a VR headset) is different.

Timeline

Start date
2023-04-19
Primary completion
2024-07-31
Completion
2024-07-31
First posted
2023-05-01
Last updated
2023-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05836662. Inclusion in this directory is not an endorsement.